Psychedelinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Decriminalization, Legalization, & Rescheduling Efforts
Group pushes to decriminalize psychedelic mushrooms in Michigan
Petition language submitted to the state Tuesday would decriminalize the production of psychedelic mushrooms and other plants for people over the age of 18.
Who Will Control the Future of Psychedelics in Colorado?
Two very different proposals could wind up on the state ballot.
Seattle Doctor Files DEA Petition To Reschedule Psilocybin For Medical Use
A Seattle doctor specializing in end-of-life care filed a formal petition with the U.S. Drug Enforcement Administration (DEA) this week challenging the government’s Schedule I classification of psilocybin, the main psychoactive component of psychedelic mushrooms. The petition, dated Tuesday, request…
Washington Bill to Legalize Psilocybin Mushroom Treatment Centers Won’t Pass
Lawmakers said they decided to slow down the process given COVID strain at the Department of Health, which would be tasked to create new rules regulating the medicine.
Oregon Psilocybin Services Act (M109)
A Niche Market Mushrooms
Treating mental health conditions is a key component of the future of legal psilocybin services in Oregon. But businesses hoping to enter the marketplace are pressing state regulators to allow creative offerings, too.
Right To Try
Federal Appeals Court Dismisses Cancer Patients’ Case To Use Psilocybin Under Right-To-Try Laws
A three-judge panel of the U.S. Court of Appeals for the Ninth Circuit has rejected a lawsuit by cancer patients and their doctor seeking access to psilocybin—the main psychoactive compound in psychedelic mushrooms—to help treat end-of-life depression and anxiety. The patients and Seattle-based pall…
Ninth Circuit ducks merits in nation’s first legal challenge to allow access to psilocybin in end-of-life care under “Right-To-Try” laws
EMERGE LAW GROUP
Bipartisan Congressional support for allowing terminal patients to seek relief from anxiety and depression in alignment with ongoing international research on the effectiveness of psilocybin in mental health care Statement The Ninth Circuit’s opinion today, January 31, 2022, finding that the agency action in this matter was not final - “the DEA’s response letter was…
Landmark Petition to Reschedule Psilocybin filed with DEA
EMERGE LAW GROUP
Bipartisan Congressional support for allowing terminal patients to seek relief from anxiety and depression in alignment with ongoing international research on the effectiveness of psilocybin in mental health care Statement Following issuance of the Ninth Circuit’s opinion in AIMS v DEA on Monday, January 31, 2022, finding lack of jurisdiction to review the DEA’s refusal to allow access…
Research, Therapy, & Science
Utah Lawmakers Vote To Study Benefits Of Psychedelics In Treating Mental Health Disorders
A Utah House committee approved a bill on Thursday that would create a task force to study and make recommendations on the therapeutic potential of psychedelic drugs and possible regulations for their lawful use. The legislation, sponsored by Rep. Brady Brammer (R), passed the House Health and Human…
Austin Texas Has The Potential To Become A Hotbed For Psychedelic Research
THE DALES REPORT
The free-spirited business leaders in the rapidly growing capital of Texas are wholeheartedly embracing opportunities for psychedelic research and therapy.
Why Scientists Invented a Magic Mushroom That Has No Magic
THE DAILY BEAST
This could be the future treatment of mood disorders like depression.
Tripp acquires EvolVR to help more people fly higher in the metaverse – TechCrunch
California-based “XR wellness and digital psychedelics platform” Tripp continues its acquisition path to growth with its acquisition of the world’s largest VR meditation community, EvolVR, following its purchase last year of PsyAssist, a mobile app used by people to keep their psy…
Subscribe to Psychedelinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
Psychedelinks by Emerge Law Group